Combination therapy with ribavirin and interferon in a cohort of children with hepatitis C and haemophilia followed at a pediatric haemophilia treatment center

Haemophilia

Volumn 10, Issue 1, 2004, Pages 87-93

  Puetz, John ^a   Thrower, M ^a   Kane, R ^a   Bouhasin, J ^a  

^a SAINT LOUIS UNIVERSITY   (United States)

Author keywords

Children; Haemophilia; Hepatitis C; Interferon; Ribavirin

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; BLOOD CLOTTING FACTOR CONCENTRATE; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN;

ADOLESCENT; ADULT; ALOPECIA; ANEMIA; ARTICLE; BLEEDING DISORDER; BLOOD TOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE COURSE; DOSE RESPONSE; DRUG ERUPTION; DRUG RESPONSE; DRUG TOLERABILITY; FLU LIKE SYNDROME; FOLLOW UP; HEMOPHILIA A; HEMOPHILIA B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; LEUKOPENIA; LIVER BIOPSY; MALE; NEUTROPENIA; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME; VIRUS LOAD;

EID: 1042304223     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.2003.00843.x     Document Type: Article

References (38)

1. Alter H. Discovery of non-A, non-B hepatitis and identification of its etiology. Am J Med 1999; 107: 16S-20S.
2. Davis G. Hepatitis C virus genotypes and quasispecies. Am J Med 1999; 107: 21S-26S.
3. Williams I. Epidemiology of hepatitis C in the United States. Am J Med 1999; 107: 2S-9S.
4. Jonas MM. Children with hepatitis C. Hepatology 2002; 36 (Suppl. 1): S173-8.
5. Blanchette V, Vorstman E, Shore A et al. Hepatitis C infection in children with hemophilia A and B. Blood 1991; 2: 285-9.
6. Shields P, Mutimer D, Muir D et al. Combined alpha interferon and ribavirin for the treatment of hepatitis C in patients with hereditary bleeding disorders. Br J Hematology 2000; 108: 254-8.
7. McHutchison J. Hepatitis C therapy in treatment-naïve patients. Am J Med 1999; 107: 56S-61S.
8. Davis G, Esteban-Mur R, Rustgi V et al. Interferon alpha-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N Engl J Med 1998; 339: 1493-9.
9. McHutchison J, Gordon S, Schiff E et al. Interferon alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998; 339: 1485-92.
10. Poynard T, McHutchison J, Goodman Z et al. Is an "A la Carte" combination interferon alpha-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C? Hepatology 2000; 31: 211-8.
11. Lackner H, Moser A, Deutsch J et al. Interferon-α and ribavirin in treating children and young adults with chronic hepatitis C after malignancy. Pediatrics 2000; 106: e53-9.
12. Suoglu O, Elkabes B, Sokucu S, Saner G. Does interferon and ribavirin combination therapy increase the rate of treatment response in children with hepatitis C? J Pediatr Gastro Nutrit 2002; 34: 199-206.
13. Christensson B, Wiebe T, Akesson A, Widell A. Interferon-α and Ribavirin treatment of hepatitis C in children with malignancy in remission. Clin Infect Dis 2000; 30: 585-6.
14. Fried MW, Peter J, Hoots K et al. Hepatitis C in adults and adolescents with hemophilia and inherited disorders of coagulation: a randomized, controlled, multicenter trial of combination therapy with interferon alfa-2b and ribavirin. Hepatology 2002; 36: 967-72.
15. Bunn S, Kelly D, Murray KF et al. Safety, efficacy and pharmacokinetics of interferon alpha 2b and ribavirin in children with chronic hepatitis C. Hepatology 2000; 32: 350A.
16. Zeuzem S, Feinman V, Rasenack J et al. Peginterferon alpha-2a in patients with chronic hepatitis C. N Engl J Med 2000; 343: 1666-72.
17. Manns M, McHutchison J, Gordon S et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet 2001; 358: 958-65.
18. Seeff L. Natural history of hepatitis C. Am J Med 1999: 107; 10S-15S.
19. Schwimmer J, Balistreri W. Transmission, natural history, and treatment strategies of hepatitis C virus infection in the pediatric population. Sem Liver Dis 2000; 20: 37-46.
20. Sinha M, Das A. Cost effectiveness analysis of different strategies of management of chronic hepatitis C infection in children. Pediatr Infect Dis J 2000; 19: 23-30.
21. Aach R, Yomtovian R, Hack M. Neonatal and pediatric posttransfusion hepatitis C: a look back and a look forward. Pediatrics 2000; 105: 836-42.
22. Yee T, Griffioen A, Sabin C, Dusheiko G, Lee C. The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985. Gut 2000; 47: 845-51.
23. Darby S, Ewart D, Giangrande P et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. Lancet 1997; 350: 1425-30.
24. Makris M, Preston P, Rosendaal F et al. The natural history of chronic hepatitis C in Haemophiliacs. Br J Hematol 1996; 94: 746-52.
25. Vogt M, Lang T, Frosner G et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med 1999: 341: 866-70.
26. Bortolotti F, Jara P, Diaz C et al. Posttransfusion and community-acquired hepatitis C in childhood. J Pedaitr Gastro Nutrit 1994; 18: 279-83.
27. Bortolotti F, Massimo M, Giacchino R et al. Hepatitis C virus infection and related liver disease in children of mothers with antibodies to the virus. J Peds 1997; 130: 990-3.
28. Chang M, Ni Y, Hwang L et al. Long term clinical and virologival outcome of primary hepatitis C virus infection in children: a prospective study. Ped Infect Dis J 1994; 13: 769-72.
29. Palomba E, Manzini P, Fiammengo P et al. Natural History of perinatal hepatitis C virus infection. Clin Infect Dis 1996; 23: 47-50.
30. Losasciulli A, Testa M, Pontisso P et al. Prevalence and natural history of hepatitis C infection in patients cured of childhood leukemia. Blood 1997; 11: 4628-33.
31. Garcia-Monzon C, Jara P, Fernandez-Bermejo M et al. Chronic hepatitis C in children: a clinical and immunohistochemical comparative study with adult patients. Hepatology 1998; 6: 1696-701.
32. Kage M, Fujisawa T, Shiraki K et al. Pathology of chronic hepatitis C in children. Hepatology 1997; 26: 771-5.
33. Badizadegan K, Jonas M, Ott M et al. Histopathology of the liver in children with chronic hepatitis C viral infection. Hepatology 1998; 28: 1416-23.
34. Guido M, Rugge M, Jara P et al. Chronic hepatitis C in children: the pathological and clinical spectrum. Gastroent 1998; 115: 1525-9.
35. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825-32.
36. Friedman S. Evaluation of fibrosis and hepatitis C. Am J Med 1999; 107; 27S-30S.
37. Zellos A, Thomas D, Mocilnikar C et al. High viral load and mild liver injury in children with hemophilia compared with other children with chronic hepatitis C virus infection. J Pediatr Gastro Nutrit 1999; 29: 418-23.
38. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-20.